Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy (RIC-NPDR)

NCT06713720 is registered in ClinicalTrials.gov with Xuxiang Zhang, MD as lead sponsor.

NCT NCT06713720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06713720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy (RIC-NPDR)
Lead sponsor
Xuxiang Zhang, MD
Phase
Not applicable
Overall status
Recruiting
Start date
April 20, 2025
Completion date
May 31, 2026
Enrollment
68 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, diabetic retinopathy, non-proliferative diabetic retinopathy, randomized controlled trial, remote ischemic conditioning